Different reactivities of enzyme-linked immunosorbent assays for hepatocyte growth factor

Clinica Chimica Acta

Volumn 402, Issue 1-2, 2009, Pages 42-46

  Fukuta, Kazuhiro ^a   Adachi, Eri ^a   Matsumoto, Kunio ^b   Nakamura, Toshikazu ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

ELISA; HGF; Reactivity

Indexed keywords

SCATTER FACTOR;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; NONHUMAN; PATHOPHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; TISSUE REGENERATION; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; CELL LINE; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; PANCREATIC ELASTASE; RATS; RATS, SPRAGUE-DAWLEY; REAGENT KITS, DIAGNOSTIC; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY;

RATTUS;

EID: 60649106519     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.12.011     Document Type: Article

References (26)

1. Nakamura T., Nawa K., and Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122 (1984) 1450-1459
2. Nakamura T., Nishizawa T., Hagiya M., et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 342 (1989) 440-443
3. Matsumoto K., and Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit Rev Oncog 3 (1992) 27-54
4. Birchmeier C., and Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 8 (1998) 404-410
5. Funakoshi H., and Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta 327 (2003) 1-23
6. Matsumoto K., and Nakamura T. Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int J Cancer 119 (2006) 477-483
7. Mizuno S., and Nakamura T. Hepatocyte growth factor: a regenerative drug for acute hepatitis and liver cirrhosis. Regen Med 2 (2007) 161-170
8. Birchmeier C., Birchmeier W., Gherardi E., and Vande Woude G.F. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4 (2003) 915-925
9. Jiang W.G., Martin T.A., Parr C., Davies G., Matsumoto K., and Nakamura T. Hepatocyte growth factor, its receptor, and their potential value in cancer therapies. Crit Rev Oncol Hematol 53 (2005) 35-69
10. Morishita R., Aoki M., Hashiya N., et al. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 44 (2004) 203-209
11. Powell R.J., Dormandy J., Simons M., Morishita R., and Annex B.H. Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trial. Vasc Med 9 (2004) 193-198
12. Nayeri F., Strömberg T., Larsson M., Brudin L., Söderström C., and Forsberg P. Hepatocyte growth factor may accelerate healing in chronic leg ulcers: a pilot study. J Dermatolog Treat 13 (2002) 81-86
13. Christensen J.G., Burrows J., and Salgia R. c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention. Cancer Lett 225 (2005) 1-26
14. Comoglio P.M., Giordano S., and Trusolino L. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov 7 (2008) 504-516
15. Yamada A., Matsumoto K., Iwanari H., et al. Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues. Biomed Res 16 (1995) 105-114
16. Tsubouchi H., Niitani Y., Hirono S., et al. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 13 (1991) 1-5
17. Ohnishi T., Kakimoto K., Hashida S., et al. Development of highly sensitive enzyme-linked immunosorbent assays for hepatocyte growth factor/scatter factor (HGF/SF): determination of HGF/SF in serum and urine from normal human subjects. J Immunol Methods 244 (2000) 163-173
18. Seki T., Ihara I., Sugimura A., et al. Isolation and expression of cDNA for different forms of hepatocyte growth factor from human leukocyte. Biochem Biophys Res Commun 172 (1990) 321-327
19. Shima N., Nagao M., Ogaki F., Tsuda E., Murakami A., and Higashio K. Tumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: cloning of its cDNA, purification and characterization of recombinant protein. Biochem Biophys Res Commun 180 (1991) 1151-1158
20. Fukuta K., Matsumoto K., and Nakamura T. Multiple biological responses are induced by glycosylation-deficient hepatocyte growth factor. Biochem J 388 (2005) 555-562
21. Gherardi E., Sandin S., Petoukhov M.V., et al. Structural basis of hepatocyte growth factor/scatter factor and MET signalling. Proc Natl Acad Sci U S A 103 (2006) 4046-4051
22. Kirchhofer D., Lipari M.T., Santell L., et al. Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist. Proc Natl Acad Sci U S A 104 (2007) 5306-5311
23. Liu K.X., Kato Y., Narukawa M., et al. Importance of the liver in plasma clearance of hepatocyte growth factors in rats. Am J Physiol 263 (1992) G642-G649
24. Appasamy R., Tanabe M., Murase N., et al. Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats. Lab Invest 68 (1993) 270-276
25. Zioncheck T.F., Richardson L., DeGuzman G.G., Modi N.B., Hansen S.E., and Godowski P.J. The pharmacokinetics, tissue localization, and metabolic processing of recombinant human hepatocyte growth factor after intravenous administration in rats. Endocrinology 134 (1994) 1879-1887
26. Uematsu Y., Fujise N., Kohsaka K., Masunaga H., and Higashio K. Effective administration route for the deleted form of hepatocyte growth factor to exert its pharmacological effects. J Pharm Sci 88 (1999) 131-135